Vishwanath Hebbi

Vishwanath Hebbi, PhD, is a Lead Scientist at Lonza since February 2022, focusing on the development of a continuous manufacturing platform train for monoclonal antibodies. Previously, as a Senior Research Scientist at Biofusion Therapeutics, Vishwanath developed purification processes for fusion monoclonal antibodies. During the doctoral research at the Indian Institute of Technology, Delhi, Vishwanath specialized in continuous downstream processing and process analytical technology for monoclonal antibodies, gaining extensive experience in chromatography and continuous process integration. Earlier career roles included Senior Scientist at Biocon, where Vishwanath developed purification processes for insulin analogues, and an Executive Trainee at USV Private Limited, contributing to cGMP batches for clinical trials. Educational qualifications include a PhD in Chemical Engineering and M.Tech in Bioprocess Technology from the Indian Institute of Technology, Delhi, along with a BE in Biotechnology from RV College of Engineering.